This country profile provides an overview of Mozambique’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
12.19 million people received treatment in Mozambique in 2019 9.33 million people did not receive treatment in Mozambique in 2019
Treatment coverage decreased from 81% in 2018 to 49% in 2019.
People needing treatment18.06m
People receiving treatment8.78m
Treatment coverage increased from 20% in 2018 to 80% in 2019.
People needing treatment4.43m
People receiving treatment3.53m
Treatment coverage increased from 51% in 2018 to 56% in 2019.
Pre-sch and school-aged children needing treatment10.86m
Pre-school and school-aged children receiving treatment6.06m
Treatment coverage increased from 60% in 2018 to 96% in 2019.
School-aged children needing treatment5.96m
School-aged children receiving treatment5.71m
Mozambique does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Mozambique.